1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 382 F.Supp.3d
  5. 382 F.Supp.3d 341 (2019)
 

EAGLE PHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC

Civil Action No. 18-1953-CFC.

382 F.Supp.3d 341 (2019)

EAGLE PHARMACEUTICALS, INC., Plaintiff, v. SLAYBACK PHARMA LLC, Defendant.

United States District Court, D. Delaware.

Filed May 9, 2019.

Editors Note
Applicable Law: 35 U.S.C. § 271
Cause: 35 U.S.C. § 271 Patent Infringement
Nature of Suit: 835 Patent - Abbreviated New Drug Application(ANDA)
Source: PACER

Attorney(s) appearing for the Case

John W. Shaw, Karen E. Keller, Nathan R. Hoeschen, SHAW KELLER LLP, Wilmington, Delaware, Counsel for Plaintiff.

Neal C. Belgam, Eve H. Ormerod, SMITH, KATZENSTEIN & JENKINS, LLP, Wilmington, Delaware, Counsel for Defendant.

REVISED MEMORANDUM OPINION

Plaintiff Eagle Pharmaceuticals, Inc. has sued Defendant Slayback Pharma LLC, alleging infringement under the doctrine of equivalents of four patents: U.S. Patent Nos. 9,265,831 (the "#831 patent"), 9,572,796 (the "#796 patent"), 9,572,797...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases